Galecto Inc (US: GLTO) — Healthcare · Share Price, Chart & Market Data
About: Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.
Sector: Healthcare
Industry: Biotechnology
Latest price: $25.41 (-1.74%)
GLTOGalecto Inc
Loading watchlist status…
Trade GLTO now
Galecto Inc share price
GLTO price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:04 am GMT+0
GLTO price performance
-4.51%
5D
-0.314%
1M
16.453%
YTD
848.134%
1Y
GLTO price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:04 am GMT+0
GLTO details
GLTO Market Signals